{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T15:39:59Z","timestamp":1726414799124},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"S5","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["MMW - Fortschritte der Medizin"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1007\/s15006-019-0743-x","type":"journal-article","created":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T12:02:37Z","timestamp":1563278557000},"page":"1-6","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Antipsychotische Pharmakotherapie bei deliranten Syndromen","Antipsychotic pharmacotherapy for delirious syndromes \u2014 only temporary, symptom-oriented and considering QTc time"],"prefix":"10.1007","volume":"161","author":[{"given":"Dirk","family":"Schwerth\u00f6ffer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans","family":"F\u00f6rstl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bastian","family":"Fatke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,16]]},"reference":[{"issue":"11","key":"743_CR1","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1007\/s00101-018-0497-3","volume":"67","author":"N. Zoremba","year":"2018","unstructured":"Zoremba N, Coburn M, Sch\u00e4lte G. Delir beim Intensivpatienten. Eine multiprofessionelle Herausforderung. Anaesthesist 2018; 67(11): 811\u2013820.","journal-title":"Anaesthesist"},{"issue":"11","key":"743_CR2","doi-asserted-by":"publisher","first-page":"1428","DOI":"10.1002\/gps.4823","volume":"33","author":"J.R. Maldonado","year":"2018","unstructured":"Maldonado JR. Delirium pathophysiology: An updated hypothesis of the etiology of acute brain failure. Int J Geriatr Psychiatry 2018; 33(11): 1428\u20131457.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"14","key":"743_CR3","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/s15006-018-0824-2","volume":"160","author":"H.J. Heppner","year":"2018","unstructured":"Heppner HJ, Zeeh J. Nah beieinander und doch verschieden. Delir oder Demenz? MMW Fortschr Med 2018; 160(14): 43\u201347.","journal-title":"MMW Fortschr Med"},{"issue":"9920","key":"743_CR4","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/S0140-6736(13)60688-1","volume":"383","author":"S.K. Inouye","year":"2014","unstructured":"Inouye SK, Westendorp RG, Saczynski JS. Delirium in elderly people. Lancet 2014; 383(9920): 911\u2013922.","journal-title":"Lancet"},{"issue":"1","key":"743_CR5","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1159\/000140804","volume":"26","author":"H. Bickel","year":"2008","unstructured":"Bickel H, Gradinger R, Kochs E et al. High risk of cognitive and functional decline after postoperative delirium. A three-year prospective study. Dement Geriatr Cogn Disord 2008; 26(1): 26\u201331.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"3","key":"743_CR6","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1080\/13651501.2017.1406955","volume":"22","author":"P. Tosun Tasar","year":"2018","unstructured":"Tosun Tasar P, Sahin S, Akcam NO et al. Delirium is associated with increased mortality in the geriatric population. Int J Psychiatry Clin Pract 2018; 22(3): 200\u2013205.","journal-title":"Int J Psychiatry Clin Pract"},{"issue":"9769","key":"743_CR7","doi-asserted-by":"publisher","first-page":"899","DOI":"10.1016\/S0140-6736(11)60341-3","volume":"377","author":"L. Fr\u00f6lich","year":"2011","unstructured":"Fr\u00f6lich L, F\u00f6rstl H. Cholinesterase inhibitor treatment in patients with delirium. Lancet 2011; 377(9769): 899; author reply 901.","journal-title":"Lancet"},{"key":"743_CR8","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1007\/s11800-007-0041-9","volume":"1","author":"H. Bickel","year":"2007","unstructured":"Bickel H. Deutsche Version der Confusion Assessment Method (CAM) zur Diagnose eines Delirs. Psychosom Konsiliarpsychiatr 2007; 1: 224. \n                    https:\/\/doi.org\/10.1007\/s11800-007-0041-9","journal-title":"Psychosom Konsiliarpsychiatr"},{"key":"743_CR9","doi-asserted-by":"publisher","first-page":"c3704","DOI":"10.1136\/bmj.c3704","volume":"341","author":"J. Young","year":"2010","unstructured":"Young J, Murthy L, Westby M et al. Diagnosis, prevention, and management of delirium: summary of NICE guidance. BMJ 2010; 341: c3704.","journal-title":"BMJ"},{"issue":"6","key":"743_CR10","doi-asserted-by":"publisher","first-page":"1041","DOI":"10.1017\/S1041610215002446","volume":"28","author":"Y. Okumura","year":"2016","unstructured":"Okumura Y, Hatta K, Wada K et al. Expert opinions on the first-line pharmacological treatment for delirium in Japan: a conjoint analysis. Int Psychogeriatr 2016; 28(6): 1041\u20131050.","journal-title":"Int Psychogeriatr"},{"issue":"1","key":"743_CR11","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1111\/jgs.13281","volume":"63","author":"S.K. Inouye","year":"2015","unstructured":"Inouye SK, Robinson T, Blaum C et al; American Geriatrics Society Expert Panel on Postoperative Delirium in Older Adults. American Geriatrics Society abstracted clinical practice guideline for postoperative delirium in older adults. J Am Geriatr Soc 2015; 63(1): 142\u2013150.","journal-title":"J Am Geriatr Soc"},{"key":"743_CR12","doi-asserted-by":"publisher","unstructured":"Korenoski A, Li A, Kane-Gill SL, Seybert AL, Smithburger PL. Pharmacologic management of delirium in the ICU: a review of the literature. J Intensive Care Med 2018. \n                    https:\/\/doi.org\/10.1177\/0885066618805965","DOI":"10.1177\/0885066618805965"},{"issue":"11","key":"743_CR13","doi-asserted-by":"publisher","first-page":"1420","DOI":"10.1002\/gps.4759","volume":"33","author":"D. Meagher","year":"2018","unstructured":"Meagher D, Agar MR, Teodorczuk A. Debate article: Antipsychotic medications are clinically useful for the treatment of delirium. Int J Geriatr Psychiatry 2018; 33(11): 1420\u20131427.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"1","key":"743_CR14","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1186\/s13643-016-0391-5","volume":"5","author":"M. Barbateskovic","year":"2016","unstructured":"Barbateskovic M, Larsen LK, Oxenboll-Collet M et al. Pharmacological interventions for delirium in intensive care patients: a protocol for an overview of reviews. Syst Rev 2016; 5(1): 211.","journal-title":"Syst Rev"},{"key":"743_CR15","first-page":"CD005594","volume":"6","author":"L. Burry","year":"2018","unstructured":"Burry L, Mehta S, Perreault MM et al. Antipsychotics for treatment of delirium in hospitalised non-ICU patients. Cochrane Database Syst Rev 2018; 6: CD005594.","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"743_CR16","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1177\/0018578717750095","volume":"53","author":"G.V. Fontaine","year":"2018","unstructured":"Fontaine GV, Mortensen W, Guinto KM et al. Newly initiated in-hospital antipsychotics continued at discharge in non-psychiatric patients. Hosp Pharm 2018; 53(5): 308\u2013315.","journal-title":"Hosp Pharm"},{"issue":"8","key":"743_CR17","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1111\/jgs.15418","volume":"66","author":"D.H. Kim","year":"2018","unstructured":"Kim DH, Mahesri M, Bateman BT et al. Longitudinal trends and variation in antipsychotic use in older adults after cardiac surgery. J Am Geriatr Soc 2018; 66(8): 1491\u20131498.","journal-title":"J Am Geriatr Soc"},{"issue":"41","key":"743_CR18","first-page":"687","volume":"108","author":"K. Wenzel-Seifert","year":"2011","unstructured":"Wenzel-Seifert K, Wittmann M, Haen E. Psychopharmakoassoziierte QTc-Intervall-Verl\u00e4ngerung und Torsade de Pointes. Dtsch Arztebl Int 2011; 108(41): 687\u2013693.","journal-title":"Dtsch Arztebl Int"},{"issue":"10","key":"743_CR19","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1055\/a-0586-3369","volume":"86","author":"J. Bohlken","year":"2018","unstructured":"Bohlken J, Hewer W, Kostev K. Inzidenz und Behandlung des nicht stoffgebundenen Delirs in deutschen Haus- und Facharztpraxen. Fortschr Neurol Psychiatr 2018; 86(10): 616\u2013623.","journal-title":"Fortschr Neurol Psychiatr"},{"issue":"3","key":"743_CR20","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1111\/anae.14472","volume":"74","author":"K.T. Ng","year":"2019","unstructured":"Ng KT, Shubash CJ, Chong JS. The effect of dexmedetomidine on delirium and agitation in patients in intensive care: systematic review and meta-analysis with trial sequential analysis. Anaesthesia 2019; 74(3): 380\u2013392.","journal-title":"Anaesthesia"},{"issue":"1","key":"743_CR21","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1016\/j.psym.2018.05.011","volume":"60","author":"J. Riviere","year":"2019","unstructured":"Riviere J, van der Mast RC, Vandenberghe J et al. Efficacy and tolerability of atypical antipsychotics in the treatment of delirium: a systematic review of the literature. Psychosomatics 2019; 60(1): 18\u201326.","journal-title":"Psychosomatics"},{"issue":"3","key":"743_CR22","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1177\/0897190017711875","volume":"31","author":"K.M. Dube","year":"2018","unstructured":"Dube KM, DeGrado J, Hohlfelder B et al. Evaluation of the effects of quetiapine on QTc prolongation in critically ill patients. J Pharm Pract 2018; 31(3): 292\u2013297.","journal-title":"J Pharm Pract"},{"issue":"8","key":"743_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1002\/phar.2146","volume":"38","author":"E. Tomaselli Muensterman","year":"2018","unstructured":"Tomaselli Muensterman E, Tisdale JE. Predictive analytics for identification of patients at risk for QT interval prolongation: a systematic review. Pharmacotherapy 2018; 38(8): 813\u2013821.","journal-title":"Pharmacotherapy"},{"issue":"3","key":"743_CR24","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1007\/s00115-005-1966-x","volume":"77","author":"W. Haverkamp","year":"2006","unstructured":"Haverkamp W, Deuschle M. Antipsychotikainduzierte QT-Verl\u00e4ngerung. Nervenarzt 2006; 77(3): 276, 278\u2013280, 282\u2013284 passim.","journal-title":"Nervenarzt"},{"issue":"8","key":"743_CR25","doi-asserted-by":"publisher","first-page":"147","DOI":"10.21037\/atm.2018.03.17","volume":"6","author":"W.S. Aronow","year":"2018","unstructured":"Aronow WS, Shamliyan TA. Effects of atypical antipsychotic drugs on QT interval in patients with mental disorders. Ann Transl Med 2018; 6(8): 147.","journal-title":"Ann Transl Med"},{"issue":"4","key":"743_CR26","doi-asserted-by":"publisher","first-page":"E8","DOI":"10.1002\/jhm.691","volume":"5","author":"C. Meyer-Massetti","year":"2010","unstructured":"Meyer-Massetti C, Cheng CM, Sharpe BA et al. The FDA extended warning for intravenous haloperidol and torsades de pointes: how should institutions respond? J Hosp Med 2010; 5(4): E8\u201316.","journal-title":"J Hosp Med"},{"issue":"12","key":"743_CR27","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/j.cjca.2017.09.001","volume":"33","author":"J. Brouillette","year":"2017","unstructured":"Brouillette J, Nattel S. A practical approach to avoiding cardiovascular adverse effects of psychoactive medications. Can J Cardiol 2017; 33(12): 1577\u20131586.","journal-title":"Can J Cardiol"},{"issue":"2","key":"743_CR28","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1007\/s11096-017-0446-2","volume":"39","author":"E. Vandael","year":"2017","unstructured":"Vandael E, Vandenberk B, Vandenberghe J et al. Development of a risk score for QTc-prolongation: the RISQ-PATH study. Int J Clin Pharm 2017; 39(2): 424\u2013432.","journal-title":"Int J Clin Pharm"},{"issue":"12","key":"743_CR29","doi-asserted-by":"publisher","first-page":"2824","DOI":"10.1111\/bcp.13740","volume":"84","author":"E. Vandael","year":"2018","unstructured":"Vandael E, Vandenberk B, Vandenberghe J et al. A smart algorithm for the prevention and risk management of QTc prolongation based on the optimized RISQ-PATH model. Br J Clin Pharmacol 2018; 84(12): 2824\u20132835.","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"743_CR30","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1007\/s11096-016-0414-2","volume":"39","author":"E. Vandael","year":"2017","unstructured":"Vandael E, Vandenberk B, Vandenberghe J et al. Risk factors for QTc-prolongation: systematic review of the evidence. Int J Clin Pharm 2017; 39(1): 16\u201325.","journal-title":"Int J Clin Pharm"},{"key":"743_CR31","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/j.jcrc.2018.07.005","volume":"47","author":"K.C. Mangan","year":"2018","unstructured":"Mangan KC, McKinzie BP, Deloney LP et al. Evaluating the risk profile of quetiapine in treating delirium in the intensive care adult population: A retrospective review. J Crit Care 2018; 47: 169\u2013172.","journal-title":"J Crit Care"},{"issue":"2","key":"743_CR32","doi-asserted-by":"publisher","first-page":"e12","DOI":"10.1002\/phar.1690","volume":"36","author":"J.W. Devlin","year":"2016","unstructured":"Devlin JW, Michaud CJ, Bullard HM et al. Quetiapine for intensive care unit delirium: the evidence remains weak. Pharmacotherapy 2016; 36(2): e12\u201313; discussion e13\u201314.","journal-title":"Pharmacotherapy"},{"key":"743_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00761-017-0195-9","volume":"23","author":"E. Jentschke","year":"2017","unstructured":"Jentschke E, Thomas M, Babiak A et al. SOP \u2014 Akuter Verwirrtheitszustand. Onkologe 2017; 23: 213\u2013217.","journal-title":"Onkologe"}],"container-title":["MMW - Fortschritte der Medizin"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-019-0743-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s15006-019-0743-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s15006-019-0743-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,23]],"date-time":"2020-09-23T05:49:44Z","timestamp":1600840184000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.springermedizin.de\/doi\/10.1007\/s15006-019-0743-x"}},"subtitle":["Nur zeitlich begrenzt, symptomorientiert und unter Beachtung der QTc-Zeit"],"short-title":[],"issued":{"date-parts":[[2019,7]]},"references-count":33,"journal-issue":{"issue":"S5","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["743"],"URL":"https:\/\/doi.org\/10.1007\/s15006-019-0743-x","relation":{},"ISSN":["1438-3276","1613-3560"],"issn-type":[{"type":"print","value":"1438-3276"},{"type":"electronic","value":"1613-3560"}],"subject":[],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"19 December 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 July 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}